Tirzepatide (Avidence Therapeutics)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameTirzepatide (Avidence Therapeutics)
Drug Alias NameTirzepatide long-acting injectable (Avidence Therapeutics)Tirzepatide LAI (Avidence Therapeutics)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidence Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvidence Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A